Bal Pharma Limited (BOM:524824)
88.84
+1.23 (1.40%)
At close: Jun 18, 2026
Bal Pharma Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 72.1 | 17.52 | 41.96 | 14.87 | 11.13 |
Short-Term Investments | 20.82 | 86.59 | 157.33 | 59.76 | 47.3 |
Cash & Short-Term Investments | 92.92 | 104.1 | 199.29 | 74.63 | 58.43 |
Cash Growth | -10.74% | -47.76% | 167.05% | 27.72% | 47.14% |
Accounts Receivable | 936.33 | 924.44 | 996.22 | 939.76 | 753.12 |
Other Receivables | - | 31.07 | 32.81 | 27.56 | 51.87 |
Receivables | 947.98 | 966.83 | 1,043 | 976.92 | 828.67 |
Inventory | 1,164 | 1,030 | 878.11 | 980.05 | 743.96 |
Prepaid Expenses | - | 13.44 | 9.69 | 7.2 | 5.86 |
Other Current Assets | 417.88 | 234.13 | 211.66 | 242.77 | 208.79 |
Total Current Assets | 2,622 | 2,349 | 2,342 | 2,282 | 1,846 |
Property, Plant & Equipment | 841.76 | 737.76 | 647.89 | 621.79 | 571.85 |
Long-Term Investments | - | 42.35 | 2.81 | 13.98 | 18.09 |
Goodwill | 38.27 | 38.27 | 38.27 | 38.29 | 38.29 |
Other Intangible Assets | 134.22 | 9.79 | 12.49 | 13.16 | 2.09 |
Long-Term Deferred Tax Assets | 8.04 | 4.1 | - | 21.67 | - |
Long-Term Deferred Charges | - | 110.18 | 101.32 | 91.41 | 77.83 |
Other Long-Term Assets | 110.77 | 65.73 | 52.82 | 48.9 | 47.53 |
Total Assets | 3,755 | 3,357 | 3,198 | 3,132 | 2,605 |
Accounts Payable | 889.68 | 816.86 | 774.64 | 789.23 | 655.64 |
Accrued Expenses | 7.76 | 73.14 | 37.77 | 34.69 | 70.82 |
Short-Term Debt | - | 1,073 | 957.61 | 927.17 | 707.49 |
Current Portion of Long-Term Debt | 1,276 | 116.7 | 74.88 | 77.6 | 58.79 |
Current Portion of Leases | - | 6.38 | 12.77 | 8.55 | 7.62 |
Current Income Taxes Payable | - | - | 22.18 | 60.06 | 43.93 |
Other Current Liabilities | 318.52 | 108.83 | 150.72 | 196.06 | 112.17 |
Total Current Liabilities | 2,492 | 2,195 | 2,031 | 2,093 | 1,656 |
Long-Term Debt | 318.85 | 314 | 363.49 | 305.23 | 270.14 |
Long-Term Leases | - | 12.9 | 13.74 | 12.25 | 22.54 |
Pension & Post-Retirement Benefits | - | 47.32 | 42.62 | 42.38 | 39.82 |
Long-Term Deferred Tax Liabilities | - | - | 15.49 | 28.69 | 6.04 |
Other Long-Term Liabilities | 121.75 | 13.64 | 12.75 | 12.8 | 25.42 |
Total Liabilities | 2,933 | 2,583 | 2,479 | 2,495 | 2,020 |
Common Stock | 159.21 | 159.21 | 158.04 | 156.9 | 148.22 |
Additional Paid-In Capital | - | 319.78 | 312.87 | 301.84 | 266.77 |
Retained Earnings | - | 297.62 | 245.04 | 171.4 | 160.33 |
Comprehensive Income & Other | 663.07 | -2.45 | 4.09 | 7.75 | 10.95 |
Total Common Equity | 822.27 | 774.16 | 720.04 | 637.89 | 586.27 |
Minority Interest | 0.25 | -0.12 | -0.33 | -0.87 | -1.34 |
Shareholders' Equity | 822.52 | 774.04 | 719.72 | 637.02 | 584.92 |
Total Liabilities & Equity | 3,755 | 3,357 | 3,198 | 3,132 | 2,605 |
Total Debt | 1,595 | 1,523 | 1,423 | 1,331 | 1,067 |
Net Cash (Debt) | -1,502 | -1,419 | -1,223 | -1,256 | -1,008 |
Net Cash Per Share | -94.43 | -89.51 | -77.73 | -80.06 | -68.02 |
Filing Date Shares Outstanding | 15.9 | 15.92 | 15.8 | 15.69 | 15.57 |
Total Common Shares Outstanding | 15.9 | 15.92 | 15.8 | 15.69 | 14.82 |
Working Capital | 130.06 | 153.72 | 311.04 | 188.22 | 189.26 |
Book Value Per Share | 51.71 | 48.63 | 45.56 | 40.66 | 39.55 |
Tangible Book Value | 649.78 | 726.1 | 669.28 | 586.45 | 545.89 |
Tangible Book Value Per Share | 40.87 | 45.61 | 42.35 | 37.38 | 36.83 |
Land | - | 172.71 | 148.93 | 148.93 | 79.1 |
Buildings | - | 239.38 | 233.21 | 222.2 | 214.15 |
Machinery | - | 763.63 | 671.8 | 613.08 | 558.05 |
Construction In Progress | - | 27.86 | 4.72 | - | 16.12 |